Successful parenteral desensitization to paclitaxel

Journal of Allergy and Clinical Immunology

Volumn 97, Issue 1 I, 1996, Pages 42-46

  Essayan, David M ^a   Kagey Sobotka, Anne ^a   Colarusso, Patrick J ^b   Lichtenstein, Lawrence M ^a   Ozols, Robert F ^b   King, Earl D ^b  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

desensitization; histamine release; Paclitaxel

Indexed keywords

DRUG VEHICLE; IMMUNOGLOBULIN E; PACLITAXEL;

ADULT; ANAPHYLAXIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CASE REPORT; DESENSITIZATION; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; HISTAMINE RELEASE; HUMAN; HYPERSENSITIVITY REACTION; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENT DISEASE; STATISTICAL ANALYSIS;

EID: 0030039047     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70281-6     Document Type: Article

References (17)

1. Arbuck SG, Donehower RC, eds. Proceedings of the Second National Cancer Institute Workshop on Taxol and Taxus. J Natl Cancer Inst 1993;15:131-9, 155-79.
2. Weiss RB, Donehower RC, Wiernik PH, et al. Hypersensitivity reactions from taxol. J Clin Oncol 1990;8:1263-8.
3. Peereboom DM, Donehower RC, Eisenhauer EA, et al. Successful re-treatment with taxol after major hypersensitivity reactions. J Clin Oncol 1993;11:885-90.
4. Laskin MS, Lucchesi KJ, Morgan M. Paclitaxel rechallenge failure after a major hypersensitivity reaction [Letter]. J Clin Oncol 1993;11:2456-7.
5. Dye D, Watkins J. Suspected anaphylactic reaction to cremophor EL. Br Med J 1980;280:1353.
6. Howrie DL, Ptachcinski RJ, Griffith BP, et al. Anaphylactoid reactions associated with parenteral cyclosporine use: possible role of cremophor EL. Drug Intell Clin Pharm 1985;19:425-7.
7. Lorenz W, Reimann H-J, Schmal A, et al. Histamine release in dogs by cremophor EL and its derivatives: oxethylated oleic acid is the most effective constituent. Agents Actions 1977;7:63-7.
8. Nolte H, Carstensen H, Hertz H. VM-26 (teniposide)-induced hypersensitivity and degranulation of basophils in children. Am J Pediatr Hematol Oncol 1988;10:308-12.
9. Sullivan TJ. Drug allergy. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: principles and practice. 4th ed. St. Louis: Mosby, 1993:1726-46.
10. Adkinson NF Jr. Measurement of total serum immunoglobulin E and allergen-specific immunoglobulin E antibody. In: Rose NR, Friedman H, eds. Manual of clinical immunology. Washington, DC: The American Society of Microbiology, 1980:800-7.
11. Sobotka AK, Dembo M, Goldstein B, Lichtenstein LM. Antigen-specific desensitization of human basophils. J Immunol 1979;122:511-7.
12. Siraganian RP. An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal Biochem 1974;57:383-94.
13. Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978;299:157-61.
14. Lorenz W. Histamine release in man. Agents Actions 1975;5:402-7.
15. Findlay SR, Dvorak AM, Kagey-Sobotka A, Lichtenstein LM. Hyperosmolar triggering of histamine release from human basophils. J Clin Invest 1981;67:1604-13.
16. Fossella FV, Lee JS, Murphy WK,. et al. Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer. J Clin Oncol 1994;12:1238-44.
17. Woodcock DM, Jefferson S, Linsenmeyer ME. Reversal of the multidrug resistance phenotype with Cremophor EL, a common vehicle for water-insoluble vitamins and drugs. Cancer Res 1990;50:4199-203.